Reference health

CONSIDERATION OF THE COST OF INTERFERON ALFA‐2b IN THE TREATMENT OF BASAL CELL CARCINOMA

https://doi.org/10.1111/j.1440-0960.1994.tb00899.x
CiteStamped reference-health badge
14/14 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 14 checked references that resolve
resolves10.1136/bmj.296.6614.13
Incidence of non-melanocytic skin cancer treated in Australia
resolves10.1016/0190-9622(91)70108-E
Metastatic basal cell carcinoma: Report of twelve cases with a review of the literature
resolves10.1111/j.1365-2133.1992.tb08050.x
Extensive and fatal basal cell carcinoma: a report of three cases
resolves10.1016/S0936-6555(05)80956-2
Treatment of non-melanoma skin cancer: A review of recent trends with special reference to the Australian scene
resolves10.1111/j.1440-0960.1992.tb00084.x
TREATMENT OF BASAL CELL CARCINOMA WITH INTRALESIONAL INTERFERON ALPHA: A CASE REPORT AND LITERATURE REVIEW
resolves10.1016/S0190-9622(86)70192-8
Treatment of basal cell carcinoma with intralesional interferon
resolves10.1016/S0140-6736(88)91620-0
TREATMENT OF LARGE BASAL-CELL CARCINOMAS WITH INTRALESIONAL INTERFERON-ALPHA-2a
resolves10.3109/09546639109089047
Treatment of basal cell carcinomas with intralesional recombinant interferonα-2b
resolves10.1016/S0190-9622(89)70246-2
Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma
resolves10.1016/S0190-9622(89)70009-8
Treatment of neoplastic skin lesions with intralesional interferon
resolves10.1001/archderm.1990.01670320053006
The Effect of an Intralesional Sustained-Release Formulation of Interferon Alfa-2b on Basal Cell Carcinomas
resolves10.1016/0190-9622(90)70276-N
Intralesional interferon therapy for basal cell carcinoma
resolves10.2165/00019053-199201010-00010
Economic Analysis as an Aid to Subsidisation Decisions
resolves10.2165/00019053-199201010-00006
Principles of Pharmacoeconomic Analysis of Drug Therapy
The 1 reference without a DOI — listed, not checked
no DOI — not checkedManual of Resource Items and Their Associated Costs
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/j.1440-0960.1994.tb00899.x"><img src="https://citestamp.com/citestamped/10.1111/j.1440-0960.1994.tb00899.x/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/j.1440-0960.1994.tb00899.x/badge.svg)](https://citestamp.com/citestamped/10.1111/j.1440-0960.1994.tb00899.x)